Latest Stock Split Details
Key information about Paradigm Biopharmaceuticals Limited's most recent stock split
Developer API
Get PAR.AX split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.03 times more shares (a 257:250 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Paradigm Biopharmaceuticals Limited's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2023-11-01 | 257:250 | No | $0.43 | $0.41 |
| 2019-04-17 | 1023:1000 | No | $1.77 | $1.73 |
About Paradigm Biopharmaceuticals Limited
Company overview and industry information
Paradigm Biopharmaceuticals Limited (PAR.AX) operates in the Biotechnology industry. The recent 257-for-250 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.